Tunstall Healthcare Announces Partnership with Leading Risk Stratification Provider, Health Intelligence

TunstallTunstall Healthcare, the leading provider of telehealth and telecare in the UK, has partnered with risk stratification provider Health Intelligence to enhance and support the delivery of its fully managed telehealthcare service, Tunstall LifeCare.

A proven risk stratification process is vital for delivering an effective telehealthcare service as it identifies the most appropriate patients for the service, accelerating benefits to service users and maximising care provision and ROI for the provider. The Tunstall LifeCare programme works in partnership with Health Intelligence, a leading provider of population-based information analytics and reporting solutions for health organisations in the UK, assisting the NHS to improve diagnosis, promote prevention and deliver cost savings.

Tunstall and Health Intelligence's 'case finding' module gives local commissioners a robust, secure and rapidly deployable solution. Patients within the population who are suitable for telehealth are identified and may be ranked in terms of their likelihood of hospital admission and hospital cost. The solution also allows commissioners, to scenario plan, prioritise those patients in greatest need, manage demand and supports GP Practices to block refer appropriate patients.

This unique approach to risk stratification offers a solution that covers all areas of the QIPP long-term conditions work stream, incorporating key areas such as statistical modelling, threshold modelling, block referrals, clinical review, service evaluation and care planning.

Simon Arnold, Managing Director at Tunstall said: "We understand that telehealth is not suitable for everyone, which is why it is important that each patient is carefully selected based on specific criteria and thresholds, such as those patients with COPD, Heart Failure or diabetes with one or more emergency admissions in the last 12 months. Our partnership with Health Intelligence helps us to proactively help clinicians in identifying the patients who will benefit most from telehealth in terms of managing their condition and helping them to live more independently."

Phil Kirby, Managing Director at Health Intelligence Ltd said: "In order to deliver maximum value, Health Intelligence partnered with Tunstall to speed up the use of telehealth services through our information analytics service, case finding, reducing the time needed to identify and refer patients to just a few weeks and to make patient referrals much easier for clinicians. This is an exciting partnership that links Health Intelligence's population based information and service delivery methodology with Tunstall's services to benefit patients, clients and commissioners."

Tunstall LifeCare is a fully managed service, providing telehealthcare at scale for the first time. It provides a fast track to achieve strategic outcomes, delivering operational benefits for commissioners, service providers and users alike. It follows a rigorous and proven process, working collaboratively with relevant stakeholders to couple wide-scale delivery with tailored service user support.

Related news articles:

About Tunstall Healthcare
Tunstall Healthcare Group is the market leading provider of telehealthcare solutions, with over 2.5 million users globally. Tunstall's solutions support older people and those with long-term needs, to live independently, by effectively managing their health and well-being. Tunstall provides technology, expertise and advice to millions of people enabling them to lead independent more fulfilling lives.

Most Popular Now

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...